At Mile High Labs, we share a collective vision for the longevity of the CBD industry. We aspire to be the CBD supply chain partner of choice for the world’s leading CPG brands. We aim to continue setting the standards for quality, compliance, traceability and consistency. Overall, we’re committed to advancing the industry forward and making CBD accessible to all through scientific innovation and research.
2016November 30th, 2016Mile High Labs is founded by Stephen Mueller
2017December 31st, 2016Mile High Labs goes from
pilot program to commercial stage
2017January 31st, 2017Expansion of labs into flagship
facility in Loveland, Colorado
2017April 1st, 201718 employees at Mile High Labs
2018May 3rd, 2017Founder Steve Mueller and CEO
Jason Roth partner to scale operations
2018July 12th, 2017Mile High Labs closes largest Series A
financing round in cannabis market history
2018August 28th, 2017Mile High’s cultivation network expands
with the passage of 2018 Farm Bill
2018October 14th, 2017Headquarters open in
downtown Boulder, Colorado
2018December 28th, 201730 employees at Mile High Labs
2019January 2nd, 2018Production capacity processing hemp
into CBD isolate grows 10X
2019February 20th, 2018The first Mile High Monster
is unveiled in Cope, Colorado
2019March 21st, 201888 Employees at Mile High Labs
Jason Roth, Chief Executive Officer of Mile High Labs, is a global innovator in pharmaceutical and medical device manufacturing and distribution, and has been awarded multiple contracts with leading food, drug & mass merchandisers. He’s built a network of over 50,000 points of distribution in FDM as well as online and
direct response retailers.
Founder & CTO
Steve Mueller is the founder, Chief Technology Officer and technical visionary of Mile High Labs. After
briefly working in electrical engineering, Steve saw the unique opportunity to capitalize on the CBD space. He’s been instrumental in the advancement of cannabinoid extraction, and his work has played a significant role in the creation of new technology, applications and processing methods.
Jon Hilley, Chief Financial Officer of
Mile High Labs, leads the Company’s capital markets activities and financial reporting compliance. Jon began
his career at Goldman Sachs before joining H.I.G. Capital as a buy-side research analyst where he learned the importance of per share value creation. This metric continues to serve as his guidelight and underpins every decision
Mile High Labs makes.
Philip Von Mecklenburg
Dr. Philip v. Mecklenburg joined Mile High Labs to create a world standard for CBD supply chains. As COO, he leads the Supply Chain Department and works with Marketing, Sales and IT teams to deliver first-class products to consumers. Philip has held a variety of executive roles in the logistics industry, both in Germany and the United States. Most recently, he was responsible for DB Schenker’s New York market and created the world’s largest Freight Marketplace.
Director of Regulatory & Compliance
Wendi Young, Director of Mile High’s Regulatory and Compliance Department, is advancing the Company’s cGMP compliance and certification efforts. Wendi spent 17 years in the pharmaceutical industry at Tolmar Inc. where she was involved in the development of over 25 products. She’s been involved in the implementation of FDA mandated changes, interpretation of new regulations and application of new controls. She also
has participated in over 20 audits from various regulatory agencies.